Biotest

Industry · 14 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) Community-acquired Pneumonia	Phase 3	2023-09-09
Terminated	Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia Respiratory Infection, Pneumonia, Community-acquired Pneumonia	Phase 3	2022-12-22
Terminated	Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssio Congenital Cytomegalovirus Infection	Phase 3	2021-11-17
Completed	Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19 Covid19	Phase 2	2020-10-06
Completed	Adjusted Fibrinogen Replacement Strategy Bleeding Disorder, Hypofibrinogenemia; Acquired	Phase 3	2018-04-03
Completed	This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP) Immune Thrombocytopenia	Phase 3	2016-11-01
Completed	Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID Primary Immunodeficiency Disease	Phase 3	2016-10-04
Completed	Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus Systemic Lupus Erythematosus	Phase 2	2015-09-28
Terminated	Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthr Rheumatoid Arthritis	Phase 2	2013-10-01
Completed	Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency Congenital Afibrinogenemia, Congenital Hypofibrinogenemia	Phase 3	2013-03-01
Completed	A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant Hepatitis B	Phase 3	2012-12-01
Completed	Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP Community Acquired Pneumonia	Phase 2	2011-08-01
Completed	Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Rheumatoid Arthritis	Phase 2	2010-12-01
Completed	Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis Psoriasis Vulgaris	Phase 2	2010-02-01